We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$40.3B
AUM Growth
-$3.3B
(-7.6%)
Cap. Flow
-$1.89B
Cap. Flow
% of AUM
-4.68%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
1,160
New
85
Increased
251
Reduced
431
Closed
113
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AVLR
Avalara, Inc.
AVLR
|
+$150M |
| 2 |
EOG Resources
EOG
|
+$128M |
| 3 |
TJX Companies
TJX
|
+$122M |
| 4 |
RTX Corp
RTX
|
+$107M |
| 5 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$365M |
| 2 |
Burlington
BURL
|
+$216M |
| 3 |
Textron
TXT
|
+$190M |
| 4 |
Dollar Tree
DLTR
|
+$126M |
| 5 |
ExxonMobil
XOM
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.31% |
| 2 | Healthcare | 17.41% |
| 3 | Financials | 15.7% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
TotalEnergies
TTE
$191B
| $3.02M | 0.01% |
65,000
| – | – |
|
|
IMGO
827
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $3.01M | 0.01% |
200,000
-25,000
| -11% | -$406K |
|
|
TMAC
828
DELISTED
The Music Acquisition Corporation
TMAC
| $2.95M | 0.01% |
300,000
| – | – |
|
829
Navigator Holdings
NVGS
$1.29B
| $2.86M | 0.01% |
250,000
+50,000
| +25% | +$569K |
|
|
NMTR
830
DELISTED
9 Meters Biopharma
NMTR
| $2.79M | 0.01% |
650,000
-64,781
| -9% | -$321K |
|
|
DO
831
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $2.79M | 0.01% |
+420,032
| New | +$2.83M |
|
|
LSI
832
DELISTED
Life Storage, Inc.
LSI
| $2.77M | 0.01% |
+25,000
| New | +$3.07M |
|
833
Martin Marietta Materials
MLM
$32.3B
| $2.75M | 0.01% |
8,551
-56,388
| -87% | -$19.1M |
|
834
Fox Class A
FOXA
$25.9B
| $2.68M | 0.01% |
87,219
-12,400
| -12% | -$420K |
|
835
United Airlines
UAL
$41.9B
| $2.66M | 0.01% |
81,809
-8,500
| -9% | -$316K |
|
836
Kimbell Royalty Partners
KRP
$1.43B
| $2.63M | 0.01% |
155,000
-91,667
| -37% | -$1.57M |
|
837
Arq
ARQ
$90.6M
| $2.51M | 0.01% |
919,900
| – | – |
|
838
COPT Defense Properties
CDP
$4.22B
| $2.5M | 0.01% |
107,559
| – | – |
|
|
BLD
839
DELISTED
TopBuild
BLD
| $2.47M | 0.01% |
+15,000
| New | +$2.77M |
|
840
ProQR Therapeutics
PRQR
$268M
| $2.46M | 0.01% |
3,300,000
| – | – |
|
841
Vaxcyte
PCVX
$8.76B
| $2.4M | 0.01% |
100,000
+47,100
| +89% | +$1.19M |
|
842
ATI
ATI
$30.5B
| $2.38M | 0.01% |
89,275
+29,275
| +49% | +$815K |
|
|
NEX
843
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $2.37M | 0.01% |
320,000
-20,000
| -6% | -$175K |
|
844
Rapid Micro Biosystems
RPID
$104M
| $2.31M | 0.01% |
716,209
-33,791
| -5% | -$131K |
|
845
Quest Diagnostics
DGX
$26.3B
| $2.31M | 0.01% |
18,800
-103,400
| -85% | -$13.6M |
|
846
Revvity
RVTY
$12.7B
| $2.24M | 0.01% |
+18,588
| New | +$2.62M |
|
|
AMAM
847
DELISTED
Ambrx Biopharma Inc
AMAM
| $2.19M | 0.01% |
2,027,291
| – | – |
|
848
Eversource Energy
ES
$27.1B
| $2.18M | 0.01% |
27,934
-331,200
| -92% | -$29.2M |
|
849
AerCap
AER
$24.4B
| $2.16M | 0.01% |
51,030
| – | – |
|
|
DEN
850
DELISTED
Denbury Inc.
DEN
| $2.16M | 0.01% |
25,000
-190,133
| -88% | -$14.6M |
|
Similar funds
Adage Capital Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Adage Capital Partners held 1,160 positions worth $40.3B, down 7.6% from $43.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners withdrew a net $1.89B in Q3 2022, closing 113 positions and reducing 431 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $101M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Avalara, Inc. worth $153M.
- Adage Capital Partners's largest Q3 2022 buy was Avalara, Inc.: 1,670,000 shares worth $153M.
- Adage Capital Partners added most to EOG Resources in Q3 2022, an estimated $128M increase.
- Adage Capital Partners's biggest Q3 2022 reduction was Royalty Pharma, cutting an estimated $365M.
- Adage Capital Partners fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $101M.
- Adage Capital Partners's ten largest holdings make up 21% of its $40.3B portfolio in Q3 2022.
- Adage Capital Partners opened 85 new positions and closed 113 in Q3 2022.
- Adage Capital Partners's portfolio value fell 7.6% quarter-over-quarter to $40.3B.
Based on Adage Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.